Skip to content

"Effects of Fluid Status and Regional Cerebral Oxygenation on Postoperative Cognitive Dysfunction in Patients Undergoing Lower Extremity Surgery Under General and Spinal Anesthesia."

"Effects of Fluid Status and Regional Cerebral Oxygenation on Postoperative Cognitive Dysfunction in Patients Undergoing Lower Extremity Surgery Under General and Spinal Anesthesia."

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07302061
Acronym
AECGSKD002
Enrollment
60
Registered
2025-12-24
Start date
2025-08-01
Completion date
2027-06-01
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Deficit (POCD)

Keywords

POCD

Brief summary

We frequently encounter cognitive impairments in patients over 65 undergoing Lower extremity surgery, depending on comorbidities and the choice of anesthesia method. The current development of neuraxial anesthesia techniques and close monitoring devices helps us prevent and detect cognitive impairment early in these patients. In this study, we aimed to investigate the effects of different anesthesia techniques (general anesthesia/spinal anesthesia) applied in orthopedic cases on patient fluid status (pleth variablity index) and regional cerebral oxygenation (NIRS), and their relationship with cognitive dysfunction.

Interventions

None listed

Sponsors

Goztepe Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over the age of 65 * Patients with an American Society of Anesthesiologists (ASA) score of II-III * Patients with a Mini Mental State Examination (MMSE) score of ≥24 on the first day before surgery

Exclusion criteria

* Patients with coagulation disorders * Patients with a history of anticoagulant medication use * Patients with advanced organ failure * Patients with Alzheimer's disease or advanced dementia * Patients with allergies to the medications used in the study * Mental Retardation * Patients with a wound infection at the site of spinal anesthesia * Patients with a history of cerebrovascular hemorrhage * Patients who did not consent;

Design outcomes

Primary

MeasureTime frameDescription
Early postoperative period (24th and 48th hours) cognitive dysfunction rateUp to 48 hours after operationWe will assess postoperative cognitive dysfunction.Cognitive function will be evaluated using the MOCA (Montreal Cognitive Assessment) at 24 and 48 hours after surgery.

Secondary

MeasureTime frameDescription
Pleth Variability Index (PVI, %) to assess intraoperative fluid statusDuring SurgeryPVI values will be continuously recorded using non-invasive monitor.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026